A multi-agent system for automating scientific discovery

Мультиагентная система для автоматизации научных открытий
Samuel G. Rodriques, Ludovico Mitchener, Jon M. Laurent, Michaela M. Hinks, Ali Essa Ghareeb, Caralyn J. Szostkiewicz, Ali Essam Ghareeb, Benjamin Chang, Angela Yiu, Caralyn J. Szostkiewicz, Dmytro Shved, Gavin J. Gyimesi, Jon M. Laurent, Samantha M. Wright, Muhammed T. Razzak, Andrew D. White, Silvia C. Finnemann, Michaela M. Hinks, Yiu Angela, Muhammed T. Razzak, Andrew D. White
2026-05-19

RNA-seqdry age-related macular degenerationhypothesis generationmulti-agent systemscientific discovery
Scientific discovery is driven by the iterative process of observation, hypothesis generation, experimentation, and data analysis. Despite recent advancements in applying artificial intelligence to biology, no system has yet automated all these stages [1, 2, 3]. Here, we introduce Robin, the first multi-agent system capable of fully automating both hypothesis generation and data analysis for experimental biology. By integrating literature search agents with data analysis agents, Robin can generate hypotheses, propose experiments, interpret experimental results, and generate updated hypotheses, achieving a semi-autonomous approach to scientific discovery. By applying this system, we were able to identify promising therapeutic candidates for dry age-related macular degeneration (dAMD), the major cause of blindness in the developed world [4, 5]. Robin proposed enhancing retinal pigment epithelium phagocytosis as a therapeutic strategy, and identified and confirmed in vitro efficacy for ripasudil and KL001. Ripasudil is a clinically-used Rho kinase (ROCK) inhibitor that has never previously been proposed for treating dAMD. To elucidate the mechanism of ripasudil-induced upregulation of phagocytosis, Robin then proposed and analyzed a follow-up RNA-seq experiment, which revealed upregulation of ABCA1 , a lipid efflux pump and possible novel target. All hypotheses, experimental directions, data analyses, and data figures in the main text of this report were produced by Robin. As the first AI system to autonomously discover and validate novel therapeutic candidates within an iterative lab-in-the-loop framework, Robin establishes a new paradigm for AI-driven scientific discovery.
1
A follow-up RNA-seq analysis proposed by Robin showed upregulation of ABCA1 after ripasudil treatment, suggesting a possible mechanistic target.
2
By integrating literature-search and data-analysis agents, Robin iteratively generates hypotheses, proposes experiments, interprets results, and updates hypotheses in a lab-in-the-loop framework.
3
Robin identified and experimentally confirmed in vitro efficacy of ripasudil and KL001 as promising therapeutic candidates for dry age-related macular degeneration.
4
Robin identified enhancement of retinal pigment epithelium phagocytosis as a therapeutic strategy for dry age-related macular degeneration.
5
Robin is presented as the first multi-agent system to automate hypothesis generation and data analysis for experimental biology.

Robin, a multi-agent system applied to experimental biology and therapeutic discovery for dry age-related macular degeneration

Fully automated, iterative generation and validation of therapeutic hypotheses through literature search, experiment proposal, experimental data analysis, and mechanism elucidation

Publication Details
Publication Date
2026-05-19
Journal
Publisher
ISSN
Cited by
297
Access Type
Author Information
Authors
Samuel G. Rodriques
Ludovico Mitchener
Jon M. Laurent
Michaela M. Hinks
Ali Essa Ghareeb
Caralyn J. Szostkiewicz
Ali Essam Ghareeb
Benjamin Chang
Angela Yiu
Caralyn J. Szostkiewicz
Dmytro Shved
Gavin J. Gyimesi
Jon M. Laurent
Samantha M. Wright
Muhammed T. Razzak
Andrew D. White
Silvia C. Finnemann
Michaela M. Hinks
Yiu Angela
Muhammed T. Razzak
Andrew D. White
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%